APA (7th ed.) Citation

F, I., LA, D., G, A., D, C., J, C., H, M., . . . JP, A. (2024). Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease-Authors' reply. Alimentary pharmacology & therapeutics, 60(8), 1141. https://doi.org/10.1111/apt.18246

Chicago Style (17th ed.) Citation

F, Idalsoaga, Díaz LA, Ayares G, Cabrera D, Chahuan J, Monrroy H, Halawi H, Arrese M, and Arab JP. "Letter: Potential Impact of Helicobacter Pylori Infection on Oesophageal Disorders in Chronic Liver Disease-Authors' Reply." Alimentary Pharmacology & Therapeutics 60, no. 8 (2024): 1141. https://doi.org/10.1111/apt.18246.

MLA (9th ed.) Citation

F, Idalsoaga, et al. "Letter: Potential Impact of Helicobacter Pylori Infection on Oesophageal Disorders in Chronic Liver Disease-Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 60, no. 8, 2024, p. 1141, https://doi.org/10.1111/apt.18246.